[1]
Chiavaroli A, di Giacomo V, De Filippis B, Cataldi A, Ferrante C, Giampietro L. The small molecule PPARγ agonist GL516 induces feeding-stimulatory effects in hypothalamus cells Hypo-E22 and isolated hypothalami. Molecules 2022; 27: 4882.
[2]
Giampietro L, Gallorini M, Gambacorta N, et al. Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors. Eur J Med Chem 2021; 224: 113737.
[3]
Giampietro L, Laghezza A, Cerchia C. Florio, R., Recinella, L., Capone, F., Ammazzalorso, A., Bruno, I., De Filippis, B., Fantacuzzi, M., Ferrante, C., Maccallini, C., Tortorella, P., Verginelli, F., Brunetti, L., Cama, A., Amoroso, R., Loiodice, F., Lavecchia, A. Novel phenyldiazenyl fibrate analogues as PPAR α/γ/δ Pan-Agonists for the amelioration of metabolic syndrome. ACS Med Chem Lett 2019; 10: 545-51.
[4]
Maccallini C, Di Matteo M, Gallorini M, et al. Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-l-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma. Eur J Med Chem 2018; 152: 53-64.
